BioNeutra Global Corp. engages in the in the business of research and development, production, and commercialization of ingredients for nutraceutical, functional, and mainstream foods and beverages. The company is headquartered in Edmonton, Alberta. The company went IPO on 2014-11-05. The Company’s lead product, VitaFiber IMO, is an advanced functional and health food ingredient naturally derived from agricultural products. VitaFiber IMO is naturally sweet and lower in calories than sugar and is a natural source of dietary fiber as it provides low calorie soluble prebiotic fiber for human digestive health. The company produces VitaFiber IMO using its patented production processes that naturally transform starch molecules from agriculture cereal crops, including tapioca, field pea or corn, into the functional health molecules of isomalto-oligosaccharide. VitaFiber IMO is also available for retail purchase across the globe through Amazon.com and Shopify.com. The Company’s customers include a mix of small and medium enterprises.
How did BGACF's recent EPS compare to expectations?
The most recent EPS for BioNeutra Global Corp is $, expectations of $.
How did BioNeutra Global Corp BGACF's revenue perform in the last quarter?
BioNeutra Global Corp revenue for the last quarter is $
What is the revenue estimate for BioNeutra Global Corp?
According to of Wall street analyst, the revenue estimate of BioNeutra Global Corp range from $ to $
What's the earning quality score for BioNeutra Global Corp?
BioNeutra Global Corp has a earning quality score of /. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.
When does BioNeutra Global Corp report earnings?
BioNeutra Global Corp next earnings report is expected in 2026-02-22
What are BioNeutra Global Corp's expected earnings?
BioNeutra Global Corp expected earnings is $, according to wall-street analysts.
Did BioNeutra Global Corp beat earnings expectations?
BioNeutra Global Corp recent earnings of $ expectations.